Dresden Glaucoma and Treatment Study (DGTS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02959242|
Recruitment Status : Recruiting
First Posted : November 9, 2016
Last Update Posted : February 23, 2021
|Condition or disease|
|Glaucoma Glaucoma, Open-Angle Glaucoma, Angle-Closure Glaucoma, Low Tension|
The aim of the study is to evaluate the quality of follow-up and treatment by means of consecutive data collection and anonymised analysis of all glaucoma patients of a tertiary university hospital glaucoma service.
Parameters being analyzed are:
Age, sex, refraction, family history, known duration of glaucoma, highest intraocular pressure before treatment, systemic and topical medication, previous ocular surgery.
24h Goldmann-applanation tonometry, biomicroscopy, gonioscopy, Heidelberg Retinal Tomograph (HRT), glaucoma diagnosis with Scanning-Laser-Polarimetry (GDx), optical coherence tomography (OCT), Pentacam, Ocular Response Analyzer (ORA), Corvis ST (Corneal Visualization with the Scheimpflug Technology), perimetry
|Study Type :||Observational|
|Estimated Enrollment :||10000 participants|
|Official Title:||Dresden Glaucoma and Treatment Study: Analysis to Assure the Quality of Follow-up and Therapy of Glaucoma Patients in a Tertiary University Hospital Glaucoma Service.|
|Study Start Date :||January 2006|
|Estimated Primary Completion Date :||December 2026|
|Estimated Study Completion Date :||December 2026|
- Follow-up intervals [ Time Frame: 20 years ]To find the best follow-up intervals for glaucoma patients.
- Assessment of treatment quality [ Time Frame: 20 years ]What is the best treatment option for the individual patient?
- Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy [ Time Frame: 20 years ]Diurnal intraocular pressure, best corrected visual acuity, visual fields
- Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy of glaucoma surgery [ Time Frame: 20 years ]Diurnal intraocular pressure, best corrected visual acuity, visual fields
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02959242
|Contact: Karin R Pillunat, MD||+49 351 458 email@example.com|
|Contact: Lutz E Pillunat, MD, PhD||+49 351 458 firstname.lastname@example.org|
|University Eye Hospital, Medical Faculty, Technical University Dresden||Recruiting|
|Dresden, Saxony, Germany, 01307|
|Contact: Karin R Pillunat, MD +49 351 458 ext 3274 email@example.com|
|Contact: Lutz E Pillunat, MD, PhD +49 351 458 ext 3381 firstname.lastname@example.org|
|Study Director:||Lutz E Pillunat, MD, PhD||Medical faculty of the Technical University of Dresden, Germany|